Newsmeme!
Discover News you didn't know existed
Bone Cancer
News
Amgen Drug for Lung Cancer Suspended After Deaths (Update3)
Published November 20, 2008, 1:47 pm, Bloomberg
Nov. 20 (Bloomberg) -- Amgen Inc. 's decision to suspend a clinical trial of its experimental cancer drug motesanib because of higher deaths among patients sets back the company's efforts to expand in the market for oncology treatments.
Tags
No tags found at this time. Be the first to tag this news item, learn more.
Imagery
Related Bone Cancer Stories
From Various News Sources
Amgen Drug for Lung Cancer Suspended After Deaths (Update3) - Bloomberg
Nov. 20 (Bloomberg) -- Amgen Inc. 's decision to suspend a clinical trial of its experimental cancer drug motesanib because of higher deaths among patients sets back the company's efforts to expand in the market for oncology treatments. Amgen, the ...
Related Social Bookmarks
None found at this time.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |